SCHEMBL5281464

SCHEMBL5281464

C=CCn1c(-c2ccccc2)cs/c1=N\N=C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.44
MAPT P10636 8/20 0.44
HTT P42858 8/20 0.44
ALDH1A1 P00352 7/20 0.44
LMNA P02545 7/20 0.43
MAPK1 P28482 6/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 3/20 0.43
PKM P14618 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
GAA P10253 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HPGD P15428 2/20 0.41
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 3/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281467 1.00 SMN1; SMN2 (0.44) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL5278251 0.82 SMN1; SMN2 (0.44) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL5278255 0.82 SMN1; SMN2 (0.44) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL4613914 0.80 ALDH1A1 (0.50) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL4613912 0.80 ALDH1A1 (0.50) SMN1; SMN2MAPTHTTALDH1A1LMNA
Hydrochloric Acid SCHEMBL4827050 0.79 ALDH1A1 (0.49) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL11017302 0.79 SMN1; SMN2 (0.63) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL11017304 0.79 SMN1; SMN2 (0.63) SMN1; SMN2MAPTHTTALDH1A1LMNA
Hydrochloric Acid SCHEMBL4827056 0.79 ALDH1A1 (0.49) SMN1; SMN2MAPTHTTALDH1A1LMNA
SCHEMBL5278267 0.78 MAPT (0.56) SMN1; SMN2MAPTHTTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT SMN1; SMN2 3523/4885MAPT 1807/4885HTT 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.